These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9160120)

  • 1. Role of adenosine as a modulator of synaptic activity in the central nervous system.
    Brundege JM; Dunwiddie TV
    Adv Pharmacol; 1997; 39():353-91. PubMed ID: 9160120
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders.
    Abbracchio MP; Ceruti S; Brambilla R; Franceschi C; Malorni W; Jacobson KA; von Lubitz DK; Cattabeni F
    Ann N Y Acad Sci; 1997 Oct; 825():11-22. PubMed ID: 9369971
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenine nucleotides as inhibitors of synaptic transmission: role of localised ectonucleotidases.
    Sebastião AM; Cunha RA; Cascalheira JF; Ribeiro JA
    Prog Brain Res; 1999; 120():183-92. PubMed ID: 10550997
    [No Abstract]   [Full Text] [Related]  

  • 4. Participation of adenosine receptors in neuroprotection.
    Ribeiro JA; Sebastiao AM; de Mendonca A
    Drug News Perspect; 2003 Mar; 16(2):80-6. PubMed ID: 12792668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous adenosine mediates the sustained inhibition of excitatory synaptic transmission during moderate hypoxia.
    Arlinghaus L; Lee KS
    Brain Res; 1996 Jun; 724(2):265-8. PubMed ID: 8828579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role and regulation of adenosine in the central nervous system.
    Dunwiddie TV; Masino SA
    Annu Rev Neurosci; 2001; 24():31-55. PubMed ID: 11283304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic inhibition of neurotransmitter release in the central nervous system.
    Ribeiro JA
    Pharmacol Toxicol; 1995 Nov; 77(5):299-305. PubMed ID: 8778740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasticity of purine release during cerebral ischemia: clinical implications?
    Pearson T; Currie AJ; Etherington LA; Gadalla AE; Damian K; Llaudet E; Dale N; Frenguelli BG
    J Cell Mol Med; 2003; 7(4):362-75. PubMed ID: 14754505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine receptors and the central nervous system.
    Sebastião AM; Ribeiro JA
    Handb Exp Pharmacol; 2009; (193):471-534. PubMed ID: 19639292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia.
    Kase H
    Biosci Biotechnol Biochem; 2001 Jul; 65(7):1447-57. PubMed ID: 11515525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation and metamodulation of synapses by adenosine.
    Ribeiro JA; Sebastião AM
    Acta Physiol (Oxf); 2010 Jun; 199(2):161-9. PubMed ID: 20345418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The mechanisms of depression by benzodiazepines, barbiturates and propofol of excitatory synaptic transmissions mediated by adenosine neuromodulation].
    Narimatsu E; Niiya T; Kawamata M; Namiki A
    Masui; 2006 Jun; 55(6):684-91. PubMed ID: 16780077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP and glutamate are released from separate neurones in the rat medial habenula nucleus: frequency dependence and adenosine-mediated inhibition of release.
    Robertson SJ; Edwards FA
    J Physiol; 1998 May; 508 ( Pt 3)(Pt 3):691-701. PubMed ID: 9518726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of adenosine in the central nervous system].
    Zhang WL; Lu GW
    Sheng Li Ke Xue Jin Zhan; 1996 Oct; 27(4):313-8. PubMed ID: 9772380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons.
    Mori A; Shindou T; Ichimura M; Nonaka H; Kase H
    J Neurosci; 1996 Jan; 16(2):605-11. PubMed ID: 8551344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.
    Concas A; Santoro G; Mascia MP; Maciocco E; Dazzi L; Ongini E; Biggio G
    J Pharmacol Exp Ther; 1993 Nov; 267(2):844-51. PubMed ID: 8246158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine modulation of calcium currents and presynaptic inhibition of GABA release in suprachiasmatic and arcuate nucleus neurons.
    Chen G; van den Pol AN
    J Neurophysiol; 1997 Jun; 77(6):3035-47. PubMed ID: 9212255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of effects of adenosine and dopamine on modification of synapses in striato-nigral and striato-pallidal neurons].
    Sil'kis IG
    Ross Fiziol Zh Im I M Sechenova; 2001 Feb; 87(2):155-69. PubMed ID: 11296702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.
    Pugliese AM; Latini S; Corradetti R; Pedata F
    Br J Pharmacol; 2003 Sep; 140(2):305-14. PubMed ID: 12970092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From energetics to neurotransmission: adenosine triphosphate and its receptors].
    Galindo F; Flores A
    Rev Neurol; 2006 Dec 1-15; 43(11):667-77. PubMed ID: 17133328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.